Clinical Trials
3 trialsNCT00449761 2021-07-15
Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase
Novartis
Phase 2 Terminated
NCT00621244 2021-01-05
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
Novartis
Phase 1/2 Completed
NCT00880269 2017-02-23
Efficacy and Safety of Panobinostat (LBH589) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)
Novartis
Phase 2 Completed